EpiAccess Control Unit A0005
by Epiep, Inc.
EpiAccess Control Unit A0005 is a Class II device made by Epiep, Inc., cleared under FDA 510(k) K170831 on 9 May 2017 and listed in FDA GUDID since 18 Sep 2017 (UDI-DI B300A00050), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | NumberB300A00050 | Date18 Sep 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK170831 | Date9 May 2017 | StatusActive |
Official records
- FDA 510(k) database K170831
Across registries
- FDA 510(k) K170831 decided 9 May 2017 Active
- FDA GUDID UDI-DI B300A00050 listed 18 Sep 2017 Listed
Timeline
- Cleared FDA 510(k) K170831
- Listed FDA GUDID B300A00050
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- EpiAccess Control Unit
- Generic name
- Cardiac catheterization monitoring system
- Model / reference
- A0005
- Primary DI / UDI-DI
- B300A00050
- 510(k) Number
- FDA product code
- DYB
- GMDN term
- Cardiac catheterization monitoring system
- Device class
- Class II
- Regulation number
- 870.1340
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code DYB (Introducer, Catheter).
- Adelante SafeSheath Ultra Lite ASUP071318P by Oscor Inc.
- Micropuncture G47949 MPIS-401-U-SST by COOK INCORPORATED
- Destino Steerable Guiding Sheath DC856717 by Oscor Inc.
- FlexCath Select Steerable Sheath (10 French) by Medtronic Cryocath, LP
- Viaseal Valved Peelable Introducer, Model 10866-XXX by Enpath Medical, Inc.
- SafeSheath® Worley 00884450483725 LVI/75-5-62-07-MP by Merit Medical Systems, Inc.
- Preface Guiding Sheath, Models 2-603M, 2-703M, 2-803M, 2-903M, 2-1003M, 2-1103M by Biosense Webster Inc
- Super Sheath R/O BT50Z07PPWX38 by TOGO MEDIKIT CO., LTD.
- Percutaneous Introducer W/Side Port 3 Way Stopcock by Daig Corp.
- DESTINATION RSR02 by TERUMO MEDICAL CORPORATION